Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Authors
Sid E. O'Bryant
Michelle M. Mielke
Robert A. Rissman
Simone Lista
Hugo Vanderstichele
Henrik Zetterberg
Piotr Lewczuk
Holly Posner
James Hall
Leigh Johnson
Yiu-Lian Fong
Johan Luthman
Andreas Jeromin
Richard Batrla-Utermann
Alcibiades Villarreal
Gabrielle Britton
Peter J. Snyder
Kim Henriksen
Paula Grammas
Veer Gupta, Edith Cowan UniversityFollow
Ralph Martins, Edith Cowan UniversityFollow
Harald Hampel
Document Type
Journal Article
Publication Title
Alzheimer's & Dementia
Publisher
Elsevier Inc
Faculty
Faculty of Health, Engineering and Sciences
School
School of Medical and Health Sciences / Center of Excellence for Alzheimer's Disease Research and Care
RAS ID
23883
DOI
10.1016/j.jalz.2016.09.014
Access Rights
subscription content
Comments
O'Bryant, S. E., Mielke, M. M., Rissman, R. A., Lista, S., Vanderstichele, H., Zetterberg, H., . . . Fong, Y. L. (2017). Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia, 13(1), 45-58. https://doi.org/10.1016/j.jalz.2016.09.014